Message #24 From:
NewsBot Date: November 16, 2005 04:23:00 AM
RGBI News ReGen Biologics Signs Exclusive Distribution Agreement for Spain
FRANKLIN LAKES, N.J.--(BUSINESS WIRE)--Nov. 16, 2005--ReGen Biologics, Inc. (OTC:RGBI) an orthopedic products company that develops, manufactures, and markets innovative tissue growth and repair products, announced today an exclusive two-year distribution agreement with Hoscenter to market the ReGen(R) CMI(TM) in most areas of Spain. The CMI is a type I collagen implant designed to facilitate growth of new tissue to replace removed or missing meniscus tissue in the human knee. Hoscenter will also market ReGen's SharpShooter(R) Tissue Repair System on a non-exclusive basis.
"Hoscenter will be an excellent partner for us in Spain, where they cover all but the Catalan area," said Gerald E. Bisbee, Jr., Ph.D., Chairman and Chief Executive Officer of ReGen Biologics. "This agreement furthers the availability of the CMI and SharpShooter in another key European market." ReGen previously announced the establishment of a wholly owned subsidiary in Switzerland as well as a distribution partner for Italy.
Speaking on behalf of Hoscenter, Enrique Garcia Fernandez, General Manager of Hoscenter remarked, "We are pleased to be working directly with ReGen Biologics in representing the CMI and SharpShooter products. There are approximately 1500 orthopedic surgeons in Spain, and they have significant interest in products such as these offering innovative approaches to orthopedic conditions."
About ReGen Biologics, Inc.
ReGen Biologics is an orthopedic products company that develops, manufactures and markets innovative tissue growth and repair products for U.S. and global markets. ReGen's first product using its patented core technology is the CMI, which uses the body's own healing process to grow new tissue in the meniscus, and restore activity levels for patients with meniscus loss. The Company's Multicenter Pivotal Clinical Trial is the largest clinical trial ever conducted involving the human meniscus. The manufacturing module was submitted to the FDA in Q3 2004. The Company expects to conclude the PMA submission with the filing of the CMI clinical module, targeted by year end 2005.
ReGen is headquartered in Franklin Lakes, NJ and manufactures the CMI in its ISO Certified facility located in Redwood City, CA. For more information on ReGen, visit www.regenbio.com.
About Hoscenter
Hoscenter is a company specializing in the distribution of medical products. They offer a wide range of arthroscopic, orthopaedic and traumatological products. Hoscenter is an ISO 9001 certified company and has been active in Spain and especially in the greater Madrid area for over 16 years. Hoscenter is headquartered in Madrid, Spain. For more information on Hoscenter visit www.hoscenter.es.
